Skip to main content

Table 2 Patient characteristics – validation cohort

From: A 3-biomarker-panel predicts renal outcome in patients with proteinuric renal diseases

Patient

Age group

Follow-up time [months]

Creatinine at time of biopsy [mg/dl]

Creatinine at follow-up [mg/dl]

eGFR (MDRD) at time of biopsy [ml/min/1.73 m 2]

eGFR (MDRD) at follow-up [ml/min/1.73 m 2]

Proteinuria at time of biopsy [g/d]

Proteinuria at follow-up [g/d]

Histological diagnosis

SD/PD

Endpoint

IFTA

GS

II

1

2

5

4.60

6.67

<20

<20

4.8

2.0

IGAN

Progressive

ESRD

Moderate

4

Moderate

2

2

51

0.88

0.96

>60

>60

1.9

1.5

IGAN

Stable

 

Moderate

2

Moderate

3

3

34

1.34

1.97

41.4

26.2

2.2

0.5

LN IV

Stable

 

Moderate

3

Moderate

4

1

23

1.09

0.98

>60

>60

3.0

0.3

LN IV

Stable

 

Moderate

2

Moderate

5

1

50

0.52

0.86

>60

>60

10.4

0.2

LN IV

Stable

 

Moderate

0

Moderate

6

1

41

1.05

5.46

>60

<20

1.7

3.3

IGAN

Progressive

ESRD

Moderate

0

None

7

3

58

0.86

8.54

>60

<20

1.3

4.6

MGN

Progressive

ESRD

Moderate

0

None

8

4

31

1.13

2.84

>60

22

2.5

2.8

MGN

Progressive

2xCrea

Moderate

0

None

9

3

25

2.59

6.61

25.5

<20

NA

NA

FSGS

Progressive

ESRD

Severe

4

NA

10

3

72

1.43

7.60

53.2

<20

NA

5.2

IGAN

Progressive

ESRD

Moderate

0

None

11

3

40

1.10

0.78

52.4

>60

NA

0.0

IGAN

Stable

 

Moderate

3

Moderate

12

3

1

4.86

6.34

<20

<20

7.9

12.5

IGAN

Progressive

ESRD

Severe

4

None

13

3

23

1.62

1.59

44.3

45.1

4.8

0.8

IGAN

Stable

 

Severe

1

Moderate

14

2

7

0.91

0.82

>60

>60

10.0

0.8

IGAN

Stable

 

None

0

None

15

4

17

1.23

4.32

58.3

<20

6.3

6.5

IGAN

Progressive

2xCrea

Moderate

2

None

16

3

16

2.71

4.16

24.2

<20

1.0

1.1

IGAN

Stable

 

Severe

3

Severe

Median

50

28

1.18

3.50

  

3.0

1.5

      

Mean

47

31

1.75

3.78

  

4.4

2.8

      

SD

15

20

1.30

2.76

  

3.3

3.3

      

Median S

46.5

28.4

1.1

0.97

  

3.0

0.6

      

Median P

49.5

28

1.33

6.48

  

3.6

4.6

      

Mean S

43.9

30.4

1.27

1.52

  

4.8

0.7

      

Mean P

49.8

31.4

2.22

6.05

  

4.1

5.3

      

SD S

12.9

16

0.67

1.15

  

3.9

0.5

      

SD P

16.9

24.8

1.64

1.81

  

2.7

3.5

      

p-value

n.s.

n.s.

n.s.

<0.001

  

n.s.

0.01

      
  1. Abbreviations see legend of Table 1.